Display options
Cite
Piacentini L, Wainwright CL, Parratt JR. Effects of Bordetella pertussis toxin pretreatment on the antiarrhythmic action of ischaemic preconditioning in anaesthetized rats. Br J Pharmacol. 1995;114(4):755-60doi: 10.1111/j.1476-5381.1995.tb13269.x.
Piacentini, L., Wainwright, C. L., & Parratt, J. R. (1995). Effects of Bordetella pertussis toxin pretreatment on the antiarrhythmic action of ischaemic preconditioning in anaesthetized rats. British journal of pharmacology, 114(4), 755-60. https://doi.org/10.1111/j.1476-5381.1995.tb13269.x
Piacentini, L, et al. "Effects of Bordetella pertussis toxin pretreatment on the antiarrhythmic action of ischaemic preconditioning in anaesthetized rats." British journal of pharmacology vol. 114,4 (1995): 755-60. doi: https://doi.org/10.1111/j.1476-5381.1995.tb13269.x
Piacentini L, Wainwright CL, Parratt JR. Effects of Bordetella pertussis toxin pretreatment on the antiarrhythmic action of ischaemic preconditioning in anaesthetized rats. Br J Pharmacol. 1995 Feb;114(4):755-60. doi: 10.1111/j.1476-5381.1995.tb13269.x. PMID: 7773535; PMCID: PMC1510211.
Copy Download .nbib Format: NLM
Share it on
Full text links
Wiley Free PMC Article

Br J Pharmacol. 1995 Feb;114(4):755-60. doi: 10.1111/j.1476-5381.1995.tb13269.x.

Effects of Bordetella pertussis toxin pretreatment on the antiarrhythmic action of ischaemic preconditioning in anaesthetized rats.

British journal of pharmacology

L Piacentini, C L Wainwright, J R Parratt

Affiliations

  1. Department of Physiology & Pharmacology, University of Strathclyde, Glasgow.

PMID: 7773535 PMCID: PMC1510211 DOI: 10.1111/j.1476-5381.1995.tb13269.x
Free PMC Article

Abstract

1. Bordetella pertussis toxin, which catalyses the ADP-ribosylation of certain guanine nucleotide binding proteins (G proteins), thus functionally uncoupling them from associated receptors, was examined to determine whether it modified the antiarrhythmic effect of ischaemic preconditioning in anaesthetized rats. 2. Pertussis toxin (25 micrograms kg-1, i.p., 48 h prior to heart isolation) attenuated the negative chronotropic effect of acetylcholine (ACh) in rat isolated Langendorff perfused hearts. ACh (10 microM) reduced heart rate by 4% in hearts taken from pertussis toxin-treated animals, compared to a reduction of 57% in hearts taken from animals treated only with vehicle. 3. In anaesthetized rats, ischaemic preconditioning (a single 3 min occlusion of the left main coronary artery followed by 10 min reperfusion) had a pronounced antiarrhythmic effect during a subsequent 30 min period of regional myocardial ischaemia. Compared to hearts receiving only a 30 min period of left coronary occlusion, there was a reduced mortality (67% and 0% for control and preconditioned groups, respectively; P < 0.01) and decreased incidences of ventricular tachycardia (VT) and ventricular fibrillation (VF). Pretreatment with pertussis toxin (25 micrograms kg-1, i.p., 48 h previously) did not modify the arrhythmias associated with a 30 min period of regional myocardial ischaemia, neither did it modify the reduction in mortality (from 56% to 0%; P < 0.05) associated with preconditioning. Furthermore, the decrease in total ventricular premature beat count induced by preconditioning seen in controls (from 427 +/- 130 to 95 +/- 45) was also seen in pertussis toxin-treated rats (from 252 +/- 190 to 57 +/- 25). 4. These results suggest that receptor coupling to pertussis toxin-sensitive G proteins is not necessary for the antiarrhythmic effect of ischaemic preconditioning in this model.

References

  1. Circ Res. 1993 Oct;73(4):649-55 - PubMed
  2. Cardiovasc Res. 1993 Apr;27(4):681-7 - PubMed
  3. Cardiovasc Res. 1993 Aug;27(8):1522-30 - PubMed
  4. Circ Res. 1993 Dec;73(6):1193-201 - PubMed
  5. Circulation. 1993 Nov;88(5 Pt 1):2351-8 - PubMed
  6. Am J Physiol. 1994 Mar;266(3 Pt 2):H1145-52 - PubMed
  7. Cardiovasc Res. 1994 Jul;28(7):1025-9 - PubMed
  8. J Pharmacol Methods. 1980 Jun;3(4):357-68 - PubMed
  9. Biochim Biophys Acta. 1984 Sep 28;801(2):232-43 - PubMed
  10. Circulation. 1986 Nov;74(5):1124-36 - PubMed
  11. Biochem Pharmacol. 1989 Feb 1;38(3):489-96 - PubMed
  12. Circ Res. 1989 Mar;64(3):437-48 - PubMed
  13. FEBS Lett. 1989 Jan 16;243(1):77-82 - PubMed
  14. Cardiovasc Res. 1988 Jul;22(7):447-55 - PubMed
  15. Annu Rev Pharmacol Toxicol. 1990;30:675-705 - PubMed
  16. Circulation. 1991 Jul;84(1):350-6 - PubMed
  17. Am Heart J. 1992 Feb;123(2):346-53 - PubMed
  18. J Mol Cell Cardiol. 1992 May;24(5):471-5 - PubMed
  19. Am J Physiol. 1992 Sep;263(3 Pt 2):H887-94 - PubMed
  20. Am J Physiol. 1992 Oct;263(4 Pt 2):H1107-12 - PubMed
  21. Cardiovasc Res. 1992 May;26(5):487-95 - PubMed
  22. Cardiovasc Res. 1992 Oct;26(10):983-7 - PubMed
  23. Cardiovasc Res. 1992 Dec;26(12):1195-8 - PubMed
  24. Am J Physiol. 1993 May;264(5 Pt 2):H1327-36 - PubMed
  25. J Mol Cell Cardiol. 1993 Mar;25(3):311-20 - PubMed
  26. Naunyn Schmiedebergs Arch Pharmacol. 1993 Apr;347(4):384-93 - PubMed
  27. Cardiovasc Res. 1993 Apr;27(4):608-11 - PubMed
  28. Cardiovasc Res. 1993 Apr;27(4):663-8 - PubMed
  29. Cardiovasc Res. 1993 Apr;27(4):674-80 - PubMed
  30. Circ Res. 1993 Oct;73(4):656-70 - PubMed

Substances

MeSH terms

Publication Types

LinkOut - more resources